GHK-Cu Research Guide: Identity, Literature, Analysis and Documentation
Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. It is one of the shortest peptides in any research catalogue and one of the few supplied as a metal complex, which changes how its certificate should be read: a report for a copper peptide has to account for the peptide and the copper separately. This page collects the identity data, the research areas the literature covers, the analytical points specific to a copper complex, and the independent reports on file for StarBio lots.
Identity
| Name | GHK-Cu (glycyl-L-histidyl-L-lysine copper(II); copper peptide; GHK-Cu2+) |
|---|---|
| Type | Copper-peptide complex of a tripeptide |
| CAS number | 89030-95-5 (complex); 49557-75-7 (free peptide GHK) |
| Molecular weight | 340.38 g/mol for the free peptide; the complex adds the mass of one copper ion |
| Formula | C14H24N6O4·Cu |
| Sequence | Gly-His-Lys |
| Length | 3 amino acids |
Origin and history
The tripeptide was isolated from human plasma in 1973 by Loren Pickart, who went on to describe its copper-binding behaviour and its decline in plasma with age. The histidine imidazole, the N-terminal amine and the backbone amide form a square-planar site that binds Cu(II) tightly, which is why the complex is blue to violet in solution and why GHK is often studied as a copper carrier rather than as a peptide alone. Most of the later literature uses the complex in skin, wound and connective-tissue models, and a smaller body of work treats it as a materials component (hydrogels, dressings).
What the literature covers
The references on file for this compound span several research areas. They are listed here as areas of study, not as results.
- Tissue remodeling reviews. Pickart’s 2008 review in the Journal of Biomaterials Science, Polymer Edition summarises three decades of work on the tripeptide [1].
- Fibroblast and matrix models in culture. Modulation of matrix metalloproteinases in wounds (1999) [4], TGF-beta secretion in dermal fibroblasts (2014) [6], and tripeptide-copper complexes on cultured fibroblasts (1995) [3].
- Experimental wound models in animals. Rat wound chambers (1993) [8]; veterinary open-wound and pad-wound studies in dogs and rabbits (1996, 2003, 2006) [5, 9, 10].
- Formulation and materials. A preformulation study characterising the native tripeptide for dermal delivery (2016) [7] and a 2025 Biomaterials Research paper on a tripeptide-copper self-healing hydrogel [2].
Much of this work is from veterinary and dermatology groups and dates from the 1990s and 2000s; the newer papers are mainly materials science. Read the model and the species before citing any of it.
Analytical notes
Two measurements matter on a GHK-Cu certificate. HPLC reports the purity of the peptide fraction as area percent, and mass spectrometry confirms the tripeptide’s mass; the copper is normally quantified separately by ICP or atomic absorption, or inferred from a colorimetric assay. The labelled mass on a vial refers to the complex, so a report that lists peptide mass and copper mass as two figures is giving you the information you need to work out the actual peptide and copper content; read both numbers rather than the headline purity alone. The free tripeptide has no aromatic residue apart from histidine, so UV detection is at low wavelength (210 to 220 nm). Free GHK and the complex are hygroscopic; weigh quickly and keep the vial sealed.
Storage and stability
- Lyophilized powder
- Store at -20 °C
- Protect from light
- Avoid repeated freeze-thaw cycles
- In solution: 2-8 °C, short term
Documentation for StarBio lots
Every StarBio lot is analysed by an independent laboratory. The Janoshik report for the 100 mg size states the peptide and the copper masses separately; the reference can be checked against the laboratory’s own record.
| Variant | Laboratory / report | HPLC purity | Labelled / measured | Tested | |
|---|---|---|---|---|---|
| GHK-Cu 100 mg | Janoshik #136402 | 99.37% | 100 mg / GHK 76.20 mg, Cu 3.27 mg | Apr 22, 2026 | report |
| GHK-Cu 50 mg | Medutest WWB-CU50-9783 | 99.58% | 50 mg | Feb 10, 2026 | report |
Current certificates are in the COA Library; the verify-lot form connects an order to its batch record.
References
- The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 2008, PMID 18644225.
- Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing. Biomaterials Research, 2025, PMID 39902373.
- Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Archives Internationales de Pharmacodynamie et de Thérapie, 1995, PMID 8836453.
- Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology, 1999, PMID 10383745.
- The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery, 2003, PMID 14648529.
- Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts. Acta Poloniae Pharmaceutica, 2014, PMID 25745767.
- Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery. Pharmaceutical Development and Technology, 2016, PMID 25384620.
- In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation, 1993, PMID 8227353.
- Effect of locally injected medications on healing of pad wounds in dogs. American Journal of Veterinary Research, 1996, PMID 8669775.
- Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Veterinary Dermatology, 2006, PMID 17083573.
Product page: GHK-Cu. Related guides: how to read a certificate, what 99% purity means, storing lyophilized peptides.
For laboratory research use only. Not for human or veterinary use.
Questions about GHK-Cu
What is GHK-Cu?
GHK-Cu is a copper-peptide complex: 3 residues (tripeptide), molecular weight 340.38 g/mol (free peptide), CAS number 89030-95-5. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.
Is GHK-Cu the same as Copper tripeptide-1 and Gly-His-Lys copper complex?
GHK-Cu is also listed as Copper tripeptide-1 and Gly-His-Lys copper complex. On a certificate or vial label, the CAS number (89030-95-5) and the sequence identify the material regardless of which name is used.
What are the CAS number, formula and molecular weight of GHK-Cu?
GHK-Cu has CAS number 89030-95-5, molecular formula C14H24N6O4·Cu and molecular weight 340.38 g/mol (free peptide). Sequence: Gly-His-Lys. Identity of each StarBio batch is confirmed by mass spectrometry on the laboratory report.
Is StarBio's GHK-Cu independently tested?
Yes. The current GHK-Cu batch was tested by Janoshik Analytical (Janoshik Analytical report #136402): 99.37% purity by HPLC, measured content GHK 76.20 mg / Cu 3.27 mg against 100 mg labelled, tested Apr 22, 2026. The report is on file in the COA library (report page). Janoshik Analytical reports can be checked on janoshik.com with the report number.
How should GHK-Cu be stored?
Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.
Where can I buy GHK-Cu for laboratory research?
StarBio sells GHK-Cu as 50 mg at $29.99 and 100 mg at $57.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.
New reports and guides, by email
A short note when a new laboratory report is published, when a compound returns to stock, and when a new guide goes up. Nothing else. Leave whenever you like.
For laboratory research use only. No dosing or protocol content is ever sent.

